US equities
|
SPCX
$161.68
▲+9.40%
MU
$908.94
▲+1.44%
TSLA
$385.85
▲+3.25%
NVDA
$220.14
▲+1.70%
SNDK
$1,376.71
▲+0.83%
META
$709.02
▲+2.13%
GOOGL
$332.37
▼-2.32%
AMD
$545.92
▲+2.09%
SPCX
$161.68
▲+9.40%
MU
$908.94
▲+1.44%
TSLA
$385.85
▲+3.25%
NVDA
$220.14
▲+1.70%
SNDK
$1,376.71
▲+0.83%
META
$709.02
▲+2.13%
GOOGL
$332.37
▼-2.32%
AMD
$545.92
▲+2.09%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Sabizabulin
Recent news which mentions Sabizabulin
Veru Stock Could Retrace Week's 45% Gain As FDA Panel Votes Against COVID-19 Drug
November 10, 2022
Tickers
BIOVF
VERU
Tags
Benzinga
VERU
Biotech
From
Benzinga
Why Veru May Be Set To Double, Triple In Price And How To Play This Consolidation Pattern
April 12, 2022
Tickers
VERU
Tags
Technicals
Top Stories
Biopharma
From
Benzinga